×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
(MP6-6) Mammalian target of rapamycin inhibitor and transarterial embolization of tuberous sclerosis complex-associated renal angiomyolipoma: a case series
2016-05-29
(MP6-5) Comparisons of functional outcomes and quality of life after neobladder reconstruction: prostate-sparing cystectomy versus radical cystoprostatectomy .
2016-05-29
(MP6-3) Systemic review of malignancy after ileocystoplasty
2016-05-29
(MP6-4) The application of HO-YAG laser in turbt with enbloc method
2016-05-29
(MP6-2) Psa flare in metastatic castration-resistant prostate cancer patients treated with abiraterone or docetaxel
2016-05-29
(MP6-1) Salvage radiotherapy for recurrence of localized prostate cancer after high-intensity focused ultrasound (HIFU)
2016-05-29
(MP5-9) Whether a good uroflow rate could guarantee a low post-void residual urine volume in men with overactive bladder?
2016-05-29
(MP5-10) The effect of low-intensity extracorporeal shock wave therapy for chronic pelvic pain syndrome
2016-05-29
(MP5-8) Subjective symptom improvement of silodosin treatment for BPH patients with unsatisfactory response to initial ɑ1 blocker
2016-05-29
(MP5-6) Up-regulation of prostatic cannabinoid receptor type 2 following capsaicin-induced prostatitis in castrated and non-castrated rats
2016-05-29
(MP5-7) Safety and therapeutic efficacy of mirabegron 25 mg in very old and frail patients with OAB and multiple comorbidities – comparison with younger patients
2016-05-29
(MP5-5) Thulium laser for tranurethral resection of Bladder tumors
2016-05-29
(MP5-3) Prognostic factors of the upper tract urothelial carcinoma pT3 patients. Single center experience 192cases in Taiwan
2016-05-29
(MP5-1) Laparoscopic retroperitoneoscopic partial nephrectomy for renal angiomyolipoma
2016-05-29
(MP5-2) Feasibility and outcomes of radical cystectomy for bladder cancer in the older patients (age>65 y/o)
2016-05-29
(MP5-4) Robotic-assisted retroperitoneoscopic partial nephrectomy for renal angiomyolipoma
2016-05-29
(MP4-10) Detecting primary upper tract urothelial cancer with by whole body FDG PET/CT
2016-05-29
(MP4-8) Outcome of laparoscopic radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level > 50 ng/ml: A single surgeon experience
2016-05-29
(MP4-9) Comparison of large renal angiomyolipoma with or without Transcatheter arterial embolization before partial nephrectomy
2016-05-29
(MP4-7) Partial cystectomy in urological practice: a single center experience
2016-05-29
(MP4-5) The oncological outcomes after pluck method laparoscopic nephroureterectomy for upper tract urothelial carcinoma
2016-05-29
(MP4-6) Neoadjvant hormone therapy for localized prostate cancer: initial experiences in intermittent-and high-risk patients in the robotic surgery era
2016-05-29
(MP4-4) Significant assosciation of interleukin-10 genotypes with renal cell carcinoma in taiwan
2016-05-29
(MP4-3) Foxp3 interacts with and regulates HIF-1-VEGF signaling in human bladder cancer
2016-05-29
<
101
102
103
104
105
106
107
108
109
110
>
/ 121